Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
CARDIOTHORACIC	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Dyspnea	O
on	O
exertion	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
-	O
Colonoscopy	O
___	O
-	O
Esophagogastroduodonoscopy	O
___	O
-	O
Capsule	O
Study	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
male	O
with	O
history	O
of	O
atrial	O
fibrillation	O
and	O
aortic	O
stenosis	O
___	O
1	O
on	O
Cardiac	O
catheterization).	O
Over	O
the	O
past	O
24	O
hours	O
he	O
presented	O
to	O
outside	O
hospital	O
with	O
complaint	O
of	O
chest	O
pain,	O
fatique,	O
weakness	O
and	O
mild	O
upper	O
back	O
pain.	O
EKG	O
with	O
chronic	O
ST	O
segment	O
changes,inferior	O
infarct,	O
anterior	O
ST	O
changes,	O
troponin	O
0.4.	O
His	O
hematocrit	O
was	O
found	O
to	O
be	O
17	O
and	O
he	O
was	O
transfused	O
with	O
2	O
units	O
PRBC.	O
Additionally	O
INR	O
was	O
elevated	O
5.7	O
related	O
to	O
coumadin	O
for	O
atrial	O
fibrillation	O
and	O
was	O
treated	O
2	O
units	O
FFP	O
and	O
Vitamin	O
K	O
10mg	O
po.	O
Due	O
to	O
recurrent	O
chest	O
pain	O
he	O
was	O
transferred	O
for	O
further	O
evaluation	O
due	O
to	O
known	O
coronary	O
artery	O
disease	O
and	O
aortic	O
stenosis.	O
He	O
was	O
seen	O
by	O
cardiac	O
surgery	O
in	O
___	O
in	O
evaluation	O
for	O
cardiac	O
surgery	O
however	O
declined	O
surgery.	O
Past	O
Medical	O
History:	O
Hard	O
of	O
hearing	O
Atrial	O
fibrillation-	O
on	O
Coumadin	O
Aortic	O
valve	O
disorder	O
___	O
1)	O
Arthritis	O
Anemia	O
recieves	O
IV	O
Iron	O
Gastroesophageal	O
reflux	O
disease	O
Colon	O
cancer	O
s/p	O
colon	O
resection	O
Prostate	O
cancer	O
s/p	O
radioactive	O
seed	O
implant	O
Social	O
History:	O
___	O
Family	O
History:	O
None	O
Physical	O
Exam:	O
Pulse:80's	O
irreg,	O
Resp:	O
14	O
O2	O
sat:	O
2l	O
98%	O
B/P	O
Right:	O
108/52	O
Left:	O
109/54	O
Height:	O
___	O
Weight:	O
80.4kg	O
General:	O
Hard	B-Hearing_impairment
of	B-Hearing_impairment
hearing,	B-Hearing_impairment
sitting	O
up	O
in	O
chair	O
no	O
acute	O
distress	O
denies	O
any	O
pain	O
Skin:	O
Dry	O
[x]	O
intact	O
[x]	O
HEENT:	O
PERRLA	O
[x]	O
EOMI	O
[x]	O
Neck:	O
Supple	O
[x]	O
Full	O
ROM	O
[x]	O
Chest:	O
Lungs	O
clear	O
bilaterally	O
[x]	O
Heart:	O
RRR	O
[]	O
Irregular	O
[x]	O
Murmur	O
___	O
syst.	O
Abdomen:	O
Soft	O
[x]	O
non-distended	O
[x]	O
non-tender	O
[x]	O
bowel	O
sounds	O
+	O
[x]	O
well	O
healed	O
mid-line	O
scar	O
s/p	O
partial	O
colectomy	O
Extremities:	O
Warm	O
[x],	O
well-perfused	O
[x]	O
Edema-	O
none	O
Varicosities-	O
minimal	O
Neuro:	O
alert	O
and	O
oriented	B-Delirium
x3	O
nonfocal	O
Pulses:	O
Femoral	O
Right:	O
2+	O
Left:2+	O
DP	O
Right:	O
1+	O
Left:1+	O
___	O
Right:	O
Doppler	O
Left:doppler	O
Radial	O
Right:	O
2+	O
Left:2+	O
Carotid	O
Bruit	O
Right:	O
None	O
Left:None	O
Pertinent	O
Results:	O
ECHO	O
___	O
The	O
left	O
atrium	O
is	O
dilated.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy.	O
The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal.	O
There	O
is	O
moderate	O
global	O
left	O
ventricular	O
hypokinesis	O
(LVEF	O
=	O
35	O
%).	O
Tissue	O
Doppler	O
imaging	O
suggests	O
an	O
increased	O
left	O
ventricular	O
filling	O
pressure	O
(PCWP>18mmHg).	O
The	O
right	O
ventricular	O
free	O
wall	O
thickness	O
is	O
normal.	O
Right	O
ventricular	O
chamber	O
size	O
is	O
normal.	O
with	O
borderline	O
normal	O
free	O
wall	O
function.	O
The	O
ascending	O
aorta	O
is	O
mildly	O
dilated.	O
There	O
are	O
focal	O
calcifications	O
in	O
the	O
aortic	O
arch.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
severely	O
thickened/deformed.	O
There	O
is	O
severe	O
aortic	O
valve	O
stenosis	O
(valve	O
area	O
0.9	O
cm2).	O
Mild	O
(1+)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Moderate	O
(2+)	O
mitral	O
regurgitation	O
is	O
seen.	O
[Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
mitral	O
regurgitation	O
may	O
be	O
significantly	O
UNDERestimated.]	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Moderate	O
[2+]	O
tricuspid	O
regurgitation	O
is	O
seen.	O
There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
Colonoscopy	O
___	O
Normal	O
terminal	O
ileum	O
Grade	O
1	O
internal	O
hemorrhoids	O
Diverticulosis	O
of	O
the	O
sigmoid	O
colon	O
No	O
avms	O
seen	O
Otherwise	O
normal	O
colonoscopy	O
to	O
cecum	O
and	O
ileum	O
EGD	O
___	O
Angioectasia	O
in	O
the	O
second	O
part	O
of	O
the	O
duodenum	O
Otherwise	O
normal	O
EGD	O
to	O
second	O
part	O
of	O
the	O
duodenum	O
Capsule	O
study	O
___	O
Nonbleeding	O
angioectasia	O
CT	O
scan	O
___	O
1.	O
Multifocal	O
patchy	O
ground-glass	O
opacities	O
predominantly	O
in	O
the	O
upper	O
lobes,	O
but	O
also	O
involve	O
the	O
RLL,	O
concerning	O
for	O
multifocal	O
PNA.	B-Lower_respiratory_tract_infection
DDx	O
also	O
includes	O
NSIP.	B-Lower_respiratory_tract_infection
2.	O
Moderate	O
bilateral	O
pleural	O
effusions,	O
without	O
evidence	O
of	O
loculation.	O
3.	O
Sub-5mm	O
solid	O
nodules	O
in	O
the	O
RML	O
and	O
RLL.	O
Punctate	O
calcified	O
granuloma	O
in	O
the	O
right	O
base.	O
Calcified	O
perihepatic	O
nodule.	O
4.	O
Significant	O
3-vessel	O
coronary	O
artery	O
disease.	O
5.	O
Small	O
amount	O
of	O
scattered	O
calcified	O
atherosclerotic	O
plaques	O
in	O
the	O
ascending	O
aorta,	O
with	O
a	O
2.8-cm	O
relatively	O
calcification-free	O
segment	O
starting	O
approximately	O
1.2	O
cm	O
superior	O
to	O
the	O
origin	O
of	O
the	O
right	O
coronary	O
artery.	O
Carotid	O
ultrasound	O
___	O
Results	O
pending	O
Brief	O
Hospital	O
Course:	O
Mr.	O
___	O
was	O
admitted	O
to	O
the	O
___	O
on	O
___	O
for	O
further	O
management	O
of	O
his	O
cardiac	O
disease	O
and	O
gastrointestinal	B-Upper_gastrointestinal_haemorrhage
bleed.	B-Upper_gastrointestinal_haemorrhage
He	O
was	O
placed	O
in	O
the	O
intensive	O
care	O
unit	O
and	O
a	O
gastroenterology	O
consult	O
was	O
obtained.	O
Anticoagulation	O
was	O
held	O
and	O
he	O
was	O
transfused	O
to	O
maintain	O
a	O
hematocrit	O
of	O
30.	O
A	O
proton	O
pump	O
inhibitor	O
was	O
started.	O
A	O
cardiology	O
consult	O
was	O
obtained	O
who	O
recommended	O
a	O
low	O
dose	O
beta	O
blocker	O
and	O
a	O
high	O
dose	O
statin	O
given	O
his	O
presentation	O
of	O
demand	O
ischemia	O
in	O
the	O
setting	O
of	O
anemia.	O
His	O
troponin	O
peaked	O
at	O
1.39.	O
An	O
EGD	O
was	O
performed	O
which	O
showed	O
angioectasia	O
that	O
were	O
not	O
bleeding	B-Upper_gastrointestinal_haemorrhage
in	O
the	O
duodenum	B-Upper_gastrointestinal_haemorrhage
with	O
an	O
otherwise	O
normal	O
study.	O
A	O
colonoscopy	O
was	O
also	O
performed	O
which	O
showed	O
diverticulum	O
and	O
internal	O
hemorrhoid	O
but	O
was	O
otherwise	O
normal.	O
He	O
was	O
transferred	O
to	O
the	O
step	O
down	O
unit	O
on	O
___	O
for	O
further	O
management	O
and	O
surgical	O
planning.	O
As	O
there	O
was	O
no	O
further	O
evidence	O
of	O
GI	O
bleeding,	O
aspirin	O
was	O
restarted.	O
A	O
capsule	O
study/virtual	O
colonoscopy	O
was	O
started	O
on	O
___	O
which	O
showed	O
non	O
bleeding	B-Upper_gastrointestinal_haemorrhage
angioectasia.	B-Upper_gastrointestinal_haemorrhage
He	O
remained	O
in	O
rate	O
controlled	O
atrial	O
fibrillation.	O
Coumadin	O
remained	O
on	O
hold	O
and	O
will	O
be	O
addressed	O
after	O
he	O
has	O
had	O
his	O
surgery.	O
Surgery	O
was	O
scheduled	O
for	O
___.	O
As	O
he	O
remained	O
stable,	O
he	O
was	O
discharged	O
home	O
on	O
___.	O
He	O
will	O
have	O
biweekly	O
hematocrits	O
sent	O
to	O
both	O
our	O
office	O
and	O
Dr.	O
___	O
drawn	O
by	O
the	O
visiting	O
nurse..	O
Surgical	O
consent	O
was	O
obtained	O
with	O
the	O
understanding	O
that	O
there	O
was	O
a	O
higher	O
risk	O
of	O
further	O
gastrointestinal	O
bleeding	O
with	O
heparinization	O
with	O
his	O
surgery.	O
Medications	O
on	O
Admission:	O
Doxazosin	O
8	O
mg	O
daily	O
Lasix	O
80	O
mg	O
daily	O
Hydroxyurea	O
1000	O
mg	O
___	O
and	O
___	O
Prilosec	O
20	O
mg	O
daily	O
Coumadin	O
5	O
mg	O
___,	O
2.5	O
mg	O
tues-thrus-sat	O
-	O
last	O
dose	O
Vitamin	O
C	O
500mg	O
daily	O
Leutin	O
1	O
tab	O
in	O
am	O
and	O
1	O
tab	O
in	O
___	O
Tylenol	O
___	O
mg	O
twice	O
a	O
day	O
Ascorbic	O
acid	O
Aspirin	O
81	O
mg	O
daily	O
Ferrous	O
sulfate	O
325	O
mg	O
TID	O
Multivitamin	O
Discharge	O
Medications:	O
1.	O
nitroglycerin	O
0.4	O
mg	O
Tablet,	O
Sublingual	O
Sig:	O
One	O
(1)	O
Tablet,	O
Sublingual	O
Sublingual	O
PRN	O
(as	O
needed)	O
as	O
needed	O
for	O
chest	O
pain.	O
Disp:*30	O
Tablet,	O
Sublingual(s)*	O
Refills:*0*	O
2.	O
omeprazole	O
40	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
One	O
(1)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
twice	O
a	O
day.	O
Disp:*60	O
Capsule,	O
Delayed	O
Release(E.C.)(s)*	O
Refills:*2*	O
3.	O
aspirin	O
81	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
DAILY	O
(Daily).	O
Disp:*90	O
Tablet,	O
Delayed	O
Release	O
(E.C.)(s)*	O
Refills:*2*	O
4.	O
ferrous	O
sulfate	O
300	O
mg	O
(60	O
mg	O
iron)	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Tablet(s)*	O
Refills:*0*	O
5.	O
metoprolol	O
tartrate	O
25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
Disp:*60	O
Tablet(s)*	O
Refills:*2*	O
6.	O
ascorbic	O
acid	O
___	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
Disp:*60	O
Tablet(s)*	O
Refills:*0*	O
7.	O
potassium	O
chloride	O
20	O
mEq	O
Tablet,	O
ER	O
Particles/Crystals	O
Sig:	O
One	O
(1)	O
Tablet,	O
ER	O
Particles/Crystals	O
PO	O
once	O
a	O
day.	O
Disp:*30	O
Tablet,	O
ER	O
Particles/Crystals(s)*	O
Refills:*0*	O
8.	O
furosemide	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Tablet(s)*	O
Refills:*0*	O
9.	O
PreserVision	O
226-200-5	O
mg-unit-mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
Disp:*60	O
Capsule(s)*	O
Refills:*0*	O
10.	O
hydroxyurea	O
500	O
mg	O
Capsule	O
Sig:	O
Two	O
(2)	O
Capsule	O
PO	O
2X/WEEK	O
(WE,SA).	O
Disp:*20	O
Capsule(s)*	O
Refills:*0*	O
11.	O
docusate	O
sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
Disp:*60	O
Capsule(s)*	O
Refills:*0*	O
12.	O
multivitamin	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Tablet(s)*	O
Refills:*0*	O
Discharge	O
Disposition:	O
Home	B-Has_carers
With	B-Has_carers
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Gastrointestinal	B-Upper_gastrointestinal_haemorrhage
bleed	B-Upper_gastrointestinal_haemorrhage
-	O
source	O
unidentified	O
in	O
setting	O
of	O
supratherapeutic	O
INR.	O
Hard	O
of	O
hearing	O
Atrial	O
fibrillation	O
-	O
Coumadin	O
currently	O
on	O
hold	O
Aortic	O
valve	O
stenosis	O
Coronary	O
artery	O
disease	O
Arthritis	O
Anemia	O
recieves	O
IV	O
Iron	O
Gastroesophageal	O
reflux	O
disease	O
Colon	O
cancer	O
s/p	O
colon	O
resection	O
Prostate	O
cancer	O
s/p	O
radioactive	O
seed	O
implant	O
Discharge	O
Condition:	O
Alert	O
and	O
oriented	B-Delirium
x3	O
nonfocal	O
Discharge	O
Instructions:	O
1)	O
You	O
will	O
need	O
twice	O
weekly	O
hematocrit	O
blood	O
draws	O
drawn	O
by	O
visiting	O
nurse.	O
2)	O
Surgery	O
scheduled	O
for	O
___.	O
You	O
will	O
be	O
contacted	O
by	O
our	O
office	O
with	O
a	O
surgical	O
time	O
so	O
you	O
know	O
when	O
to	O
arrive	O
at	O
the	O
hospital	O
on	O
___.	O
3)	O
Visiting	O
nurse	O
to	O
monitor	O
you	O
for	O
signs	O
of	O
heart	O
failure.	O
4)	O
Call	O
with	O
any	O
blood	B-Lower_gastrointestinal_haemorrhage
in	O
stools,	B-Lower_gastrointestinal_haemorrhage
dark/tarry	I-Upper_gastrointestinal_haemorrhage
stools	B-Upper_gastrointestinal_haemorrhage
or	O
abdominal	O
pain.	O
5)	O
Call	O
with	O
any	O
questions	O
or	O
concerns.	O
Followup	O
Instructions:	O
___	O

